SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Meyler's Side Effects of Drugs, 2016,

    CrossRef

  2. 2
    Yoshitaka Okamoto, Nobuo Ohta, Mitsuhiro Okano, Atsushi Kamijo, Minoru Gotoh, Motohiko Suzuki, Sachio Takeno, Tetsuya Terada, Toyoyuki Hanazawa, Shigetoshi Horiguchi, Kohei Honda, Shoji Matsune, Takechiyo Yamada, Atsushi Yuta, Takeo Nakayama, Shigeharu Fujieda, Guiding principles of subcutaneous immunotherapy for allergic rhinitis in Japan, Auris Nasus Larynx, 2014, 41, 1, 1

    CrossRef

  3. 3
    Joaquín Quiralte, José L Justicia, Victoria Cardona, Ignacio Dávila, Estefanía Moreno, Berta Ruiz, Mario A García, Is faster safer? Cluster versus short conventional subcutaneous allergen immunotherapy, Immunotherapy, 2013, 5, 12, 1295

    CrossRef

  4. 4
    Alfredo Iglesias-Cadarso, Pilar Hernández-Weigand, Risk factors for systemic reactions to allergen immunotherapy, Current Opinion in Allergy and Clinical Immunology, 2011, 11, 6, 579

    CrossRef

  5. 5
    Nerin Nadir Bahceciler, Nazan Cobanoglu, Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma, Immunotherapy, 2011, 3, 6, 747

    CrossRef

  6. 6
    C. Barth, F. Anero, O. Pfaar, L. Klimek, K. Hörmann, B. A. Stuck, Safety aspects of subcutaneous immunotherapy with multiple allergens—a retrospective analysis on polysensitized patients, European Archives of Oto-Rhino-Laryngology, 2010, 267, 12, 1873

    CrossRef

  7. 7
    Anaïs Pipet, Karine Botturi, Domitille Pinot, Daniel Vervloet, Antoine Magnan, Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy, Respiratory Medicine, 2009, 103, 6, 800

    CrossRef

  8. 8
    Pilar Serrano, José-Luis Justicia, Cesárea Sánchez, Mercedes Cimarra, Laureano Fernández-Távora, Agustín Orovitg, Carmen Moreno, Francisco Guerra, Víctor Alvà, Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity–standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study, Annals of Allergy, Asthma & Immunology, 2009, 102, 3, 247

    CrossRef

  9. 9
    Hugh H Windom, Richard F Lockey, An update on the safety of specific immunotherapy, Current Opinion in Allergy and Clinical Immunology, 2008, 8, 6, 571

    CrossRef

  10. 10
    Ana I. Tabar, María T. Lizaso, Blanca E. García, Belen Gómez, Susana Echechipía, María T. Aldunate, Begoña Madariaga, Alberto Martínez, Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: Clinical efficacy and safety, Pediatric Allergy and Immunology, 2008, 19, 1
  11. 11
    A. Didier, F. de Blay, L. Tetu, J.C. Dubus, A. Grimfeld, J. Just, P. Demoly, Existe-t-il des traitements spécifiques pour l’asthmatique allergique ?, Revue des Maladies Respiratoires, 2007, 24, 8, 41

    CrossRef

  12. 12
    M. Casanovas, R. Martín, C. Jiménez, R. Caballero, E. Fernández-Caldas, Safety of immunotherapy with therapeutic vaccines containing depigmented and polymerized allergen extracts, Clinical & Experimental Allergy, 2007, 37, 3
  13. 13
    Enrique Fernández-Caldas, Victor Iraola, Manuel Boquete, Antonio Nieto, Miguel Casanovas, Mite immunotherapy, Current Allergy and Asthma Reports, 2006, 6, 5, 413

    CrossRef

  14. 14
    Subcutaneous immunotherapy, Allergy, 2006, 61,
  15. 15
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  16. 16
    Miguel Casanovas, Enrique Fern&aacute;ndez-Caldas, Remedios Alamar, Antonio Basomba, Comparative Study of Tolerance between Unmodified and High Doses of Chemically Modified Allergen Vaccines of <i>Dermatophagoides pteronyssinus</i>, International Archives of Allergy and Immunology, 2005, 137, 3, 211

    CrossRef

  17. 17
    P. Gamboa, G. González, I. Jauregui, G. Jorró, I. Molero, J.L. Eseverri, R. González, I. Luna, C. Marcos, J. Miró, Z. Pulido, T. Gracia, P. Iriarte, A. Carreño, J.A. Navarro, S. Rocafort, J.C. García-Robaina, I. Souto, R. Casas, R. Lleonart, S. Nevot, O. Asensio, M. Bosque, A. Blasco, F. de la Torre, A prospective and multicenter safety-monitoring study of a short up-dosing schedule of immunotherapy with a mass-units-standardized extract of mites, Allergologia et Immunopathologia, 2004, 32, 1, 13

    CrossRef

  18. 18
    A. Iglesias-Cadarso, P. Hernández-Weigand, M. Reaño, I. Herrera, L. Sánchez-Morillas, A. Pérez-Pimiento, A prospective safety study of allergen immunotherapy in daily clinical practice, Allergologia et Immunopathologia, 2004, 32, 5, 278

    CrossRef

  19. 19
    C. Moreno, J. Cuesta-Herranz, L. Fernández-Távora, E. Alvarez-Cuesta, Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases, Clinical & Experimental Allergy, 2004, 34, 4
  20. 20
    E Alvarez-Cuesta, A Beristain, Practical management of immunotherapy, Revue Française d'Allergologie et d'Immunologie Clinique, 2003, 43, 5, 301

    CrossRef

  21. 21
    Eustachio Nettis, Daniela Giordano, Antonio Ferrannini, Alfredo Tursi, Systemic Reactions to Allergen Immunotherapy: A Review of the Literature, Immunopharmacology and Immunotoxicology, 2003, 25, 1, 1

    CrossRef

  22. 22
    G. Gastaminza, J. Algorta, M. Audicana, M. Etxenagusia, E. Fernández, D. Muñoz, Systemic reactions to immunotherapy: influence of composition and manufacturer, Clinical & Experimental Allergy, 2003, 33, 4
  23. 23
    Antonio Basomba, Ana I. Tabar, Dolores Hernández F. de Rojas, Blanca E. García, Remedios Alamar, José M. Olaguíbel, Jaime Moscoso del Prado, Santiago Martín, Pilar Rico, Allergen vaccination with a liposome-encapsulated extract of Dermatophagoides pteronyssinus : A randomized, double-blind, placebo-controlled trial in asthmatic patients, Journal of Allergy and Clinical Immunology, 2002, 109, 6, 943

    CrossRef

  24. 24
    M. K. Kägi, B. Wüthrich, Different methods of local allergen-specific immunotherapy, Allergy, 2002, 57, 5
  25. 25
    E. Nettis, D. Giordano, A. Pannofino, A. Ferrannini, A. Tursi, Safety of inhalant allergen immunotherapy with mass units-standardized extracts, Clinical & Experimental Allergy, 2002, 32, 12
  26. 26
    Stephen F. Kemp, ADVERSE EFFECTS OF ALLERGEN IMMUNOTHERAPY, Immunology and Allergy Clinics of North America, 2000, 20, 3, 571

    CrossRef

  27. 27
    L. Winther, H.-J. Malling, H. Mosbech, Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects, Allergy, 2000, 55, 9
  28. 28
    P. Van Cauwenberge, C. Bachert , G. Passalacqua , J. Bousquet , G. W. Canonica , S. R. Durham , W. J. Fokkens , P. H. Howarth , V. Lund , H.-J. Malling , N. Mygind , D. Passali , G. K. Scadding , D.-Y. Wang , Consensus statement on the treatment of allergic rhinitis, Allergy, 2000, 55, 2
  29. 29
    James T. Li, IMMUNOTHERAPY FOR ALLERGIC RHINITIS, Immunology and Allergy Clinics of North America, 2000, 20, 2, 383

    CrossRef

  30. 30
    E. Alvarez-Cuesta, E. Gonzélez-Mancebo, Immunotherapy in bronchial asthma, Current Opinion in Pulmonary Medicine, 2000, 6, 1, 50

    CrossRef

  31. 31
    Necla Akçakaya, Ahmad Hassanzadeh, Yildiz Camcioğlu, Haluk Çokuğraş, Local and systemic reactions during immunotherapy with adsorbed extracts of house dust mite in children, Annals of Allergy, Asthma & Immunology, 2000, 85, 4, 317

    CrossRef

  32. 32
    M. T. Mellerup, G. W. Hahn, L. K. Poulsen, H.-J. Malling, Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment, Clinical & Experimental Allergy, 2000, 30, 10
  33. 33
    Allergen immunotherapy: therapeutic vaccines for allergic diseases, Allergy, 1998, 53,
  34. 34
    H.J. Malling, Current place of allergen-specific immunotherapy in asthma and rhinitis, Revue Française d'Allergologie et d'Immunologie Clinique, 1998, 38, 7, S232

    CrossRef

  35. 35
    H.-J. Mailing, Immunotherapy as an effective tool in allergy treatment, Allergy, 1998, 53, 5
  36. 36
    H.-J. Malling, J. Abreu-Nogueira, E. Alvarez-Cuesta, B. Björkstén, J. Bousquet, D. Caillot, G. W. Canonica, G. Passalacqua, P. Saxonis-Papageorgiou, E. Valovirta, Local immunotherapy, Allergy, 1998, 53, 10
  37. 37
    B. Rogala, Risk and safety of immunotherapy, Allergy, 1998, 53, 5
  38. 38
    Yoshihiro Ohashi, Yoshiaki Nakai, Ayaki Tanak, Risk Factors for Adverse Systemic Reactions Occurring during Immunotherapy with Standardized Dermatophagoides farinae Extracts, Acta Oto-Laryngologica, 1998, 118, 538, 113

    CrossRef

  39. 39
    R. Fadel, C. Andre, M. Bellanger, N. Bonardel, M.J. Brunet-Moret, C. Castelain, Y. Caubet, B. Dollois, M.T. Guinnepain, M. Larchevesque, F. Leynadier, P. Nicolas, M. Raffard, F. Saada-Buisson, F. Suard-Boix, Tolérance, compliance et efficacité de l'immunothérapie spécifique par des extraits allergéniques aqueux ou adsorbés sur phosphate de calcium, Revue Française d'Allergologie et d'Immunologie Clinique, 1998, 38, 1, 41

    CrossRef

  40. 40
    C. González Cuesta, R. Feijoo, P. Rico, A prospective safety-monitoring study of immunotherapy in mite-allergy patients with mass-units-standardized extract, Allergy, 1997, 52, 5
  41. 41
    J. M. Olaguibel, A. I. Tabar, B. E. García Figueroa, C. Cortés, Immunotherapy with standardized extract of Dermatophagoides pteronyssinus in bronchial asthma: a dose-titration study, Allergy, 1997, 52, 2
  42. 42
    Lone Nielsen, Claus R. Johnsen, Holger Mosbech, Lars K. Poulsen, Hans-Jørgen Malling, Antihistamine premedication in specific cluster immunotherapy: A double-blind, placebo-controlled study, Journal of Allergy and Clinical Immunology, 1996, 97, 6, 1207

    CrossRef

  43. 43
    John T. Chiu, Name Withheld, Charles B. Kahn, Julie Stielstra, Letters to the Editor, Hospital Practice, 1996, 31, 10, 36

    CrossRef

  44. 44
    F. Duce Gracia, J. Fraj Lázaro, Tratamiento desensibilizante en el asma bronquial, Archivos de Bronconeumología, 1996, 32, 8, 414

    CrossRef

  45. 45
    J.C. Bessot, Désensibilisation spécifique : bilan dans différentes pathologies allergiques, Revue Française d'Allergologie et d'Immunologie Clinique, 1994, 34, 6, 501

    CrossRef

  46. 46
    H.-J. MALLING, Immunotherapy in Europe, Clinical & Experimental Allergy, 1994, 24, 6
  47. 47
    Hans-Jørgen Malling, What Is the Role of Immunotherapy in Allergic Diseases?, Clinical Immunotherapeutics, 1994, 2, 4, 240

    CrossRef